about
Impact of apolipoprotein A5 variants on statin treatment efficacyAPOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean populationThe association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE studyAssociation of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.The APOA1/C3/A4/A5 cluster and markers of allostatic load in the Boston Puerto Rican Health Study.Absence of Association between -1131T>C Polymorphism in the Apolipoprotein APOA5 Gene and Pediatric Metabolic Syndrome.Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategiesVitamin D dependent effects of APOA5 polymorphisms on HDL cholesterolStructural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.Personalized vascular medicine: individualizing drug therapyNew technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia.Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure.Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathwayImpact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.Genetic markers associated to dyslipidemia in HIV-infected individuals on HAART.
P2860
Q28248690-1483863F-9E27-4F5D-8D97-FEBF683B8B6EQ28302513-1369EB1A-C37B-430A-9E3C-8AEB5902C96BQ28306572-ECAD40C5-AC00-491B-9C65-596DCE62CAA3Q33653008-0247DA69-BAD5-42EE-8CB4-94A07243725EQ34415298-44E71797-9CE7-4F90-BD7E-965CF8C0C96CQ34772919-F736C0FA-B848-4D5B-BD8F-73975A12A2E5Q35884548-0A59E244-4CD9-4C4C-A030-41AD5B916B9DQ35907312-3923DEB0-CC2B-40B1-B296-8D46F704BB30Q36744086-F1EB11D7-D130-4D4D-9854-8E67902DB092Q37142852-167FACE9-65E1-4479-8959-1E9F0DE749FBQ37331223-E8ECB671-6AF2-4CAE-9BA0-34A77CAEC68FQ37401949-1612D359-B6BA-4EAA-9852-A89A64E29716Q37421221-2F66FCA2-DC02-4CDC-A76F-851B4CC982FBQ37728366-61DDC354-1321-4A4A-AB48-F393932C0492Q42362094-C6FB976E-C837-48CF-A99F-03A6F9000B5AQ48897669-D3951136-B88E-431A-BAD5-38AA0E3B11F5Q51860323-616336FF-7B08-449B-9F72-3A1F495BCA18
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Clinical significance of apolipoprotein A5
@ast
Clinical significance of apolipoprotein A5
@en
Clinical significance of apolipoprotein A5
@nl
type
label
Clinical significance of apolipoprotein A5
@ast
Clinical significance of apolipoprotein A5
@en
Clinical significance of apolipoprotein A5
@nl
prefLabel
Clinical significance of apolipoprotein A5
@ast
Clinical significance of apolipoprotein A5
@en
Clinical significance of apolipoprotein A5
@nl
P2860
P1476
Clinical significance of apolipoprotein A5
@en
P2860
P304
P356
10.1097/MOL.0B013E328304B681
P407
P577
2008-08-01T00:00:00Z